These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36604598)

  • 1. Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation.
    Du G; Zhao L; Zheng Y; Belfetmi A; Cai T; Xu B; Heyninck K; Van Den Heede K; Buyse MA; Fontana P; Bowman M; Lin LL; Wu H; Chou JJ
    Cell Res; 2023 Feb; 33(2):131-146. PubMed ID: 36604598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.
    Tur V; van der Sloot AM; Reis CR; Szegezdi E; Cool RH; Samali A; Serrano L; Quax WJ
    J Biol Chem; 2008 Jul; 283(29):20560-8. PubMed ID: 18474604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HPLC method associated with a thermodynamic analysis to compare the binding of TRAIL and its nanovectorized form to death receptors DR4 and DR5 and their relationship to cytotoxicity.
    Guillaume YC; Lethier L; André C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():142-148. PubMed ID: 27750195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
    FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
    Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
    Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.
    Zhang P; Zheng Y; Shi J; Zhang Y; Liu S; Liu Y; Zheng D
    J Biol Chem; 2010 Mar; 285(12):8953-66. PubMed ID: 20106985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.
    Lemke J; Noack A; Adam D; Tchikov V; Bertsch U; Röder C; Schütze S; Wajant H; Kalthoff H; Trauzold A
    J Mol Med (Berl); 2010 Jul; 88(7):729-40. PubMed ID: 20354842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Extracellular Domain of Death Receptor 5 Inhibits TRAIL-Induced Apoptosis by Disrupting Receptor-Receptor Interactions.
    Vunnam N; Lo CH; Grant BD; Thomas DD; Sachs JN
    J Mol Biol; 2017 Sep; 429(19):2943-2953. PubMed ID: 28834692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling.
    Pan L; Fu TM; Zhao W; Zhao L; Chen W; Qiu C; Liu W; Liu Z; Piai A; Fu Q; Chen S; Wu H; Chou JJ
    Cell; 2019 Mar; 176(6):1477-1489.e14. PubMed ID: 30827683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
    Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized.
    Valley CC; Lewis AK; Mudaliar DJ; Perlmutter JD; Braun AR; Karim CB; Thomas DD; Brody JR; Sachs JN
    J Biol Chem; 2012 Jun; 287(25):21265-78. PubMed ID: 22496450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.
    Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S
    Anal Cell Pathol (Amst); 2010; 33(5):229-44. PubMed ID: 20978316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
    Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
    Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
    Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.
    Wassenaar TA; Quax WJ; Mark AE
    Proteins; 2008 Feb; 70(2):333-43. PubMed ID: 17671978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.
    Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S
    Cell Oncol (Dordr); 2011 Jun; 34(3):245-59. PubMed ID: 21538027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule activation of the TRAIL receptor DR5 in human cancer cells.
    Wang G; Wang X; Yu H; Wei S; Williams N; Holmes DL; Halfmann R; Naidoo J; Wang L; Li L; Chen S; Harran P; Lei X; Wang X
    Nat Chem Biol; 2013 Feb; 9(2):84-9. PubMed ID: 23292651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
    Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H
    J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.
    Pavet V; Beyrath J; Pardin C; Morizot A; Lechner MC; Briand JP; Wendland M; Maison W; Fournel S; Micheau O; Guichard G; Gronemeyer H
    Cancer Res; 2010 Feb; 70(3):1101-10. PubMed ID: 20103630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
    Thomas LR; Johnson RL; Reed JC; Thorburn A
    J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.